Abstract
Thymoma is a unique neoplasm of the anterior mediastinum that is frequently associated with indolent growth and a variety of paraneoplastic syndromes. One third of cases are detected during the evaluation of myasthenia gravis. Classification systems of thymoma have limited ability in accurately predicting prognosis and course of disease. Thus, staging is the only way to predict clinical behavior. Encapsulated tumors that are surgically resected carry the best prognosis. Adjuvant radiotherapy is recommended for incompletely excised and most invasive thymomas. Chemotherapy in anthracycline-based chemotherapy remains the most effective chemotherapy for neoadjuvant, adjuvant or palliative treatment.
Similar content being viewed by others
References
Miller JF. Thymus and immunity–II. The last three decades. Eur J Cancer Clin Oncol. 1988;24(8):1257–62.
Mller-Hermelink HK, Wilisch A, Schultz A, Marx A. Characterization of the human thymic microenvironment: lymphoepithelial interaction in normal thymus and thymoma. Arch Histol Cytol. 1997;60(1):9–28.
Rosen FS. The primary immunodeficiencies. N Engl J Med. 1984;311(5):300.
Thomas CR. Thymoma: State of the art. J Clin Oncol. 1999;17(7):2280.
Gerein AN. Thymoma: A ten year review. Am J Surg. 1978;136(1):49.
Engels EA. Malignant thymoma in the United States: Demographic patterns in incidence and associations with subsequent malignancies. Int J Cancer. 2003;105(4):546.
Mullen B. Primary anterior mediastinal tumors in children and adults. Ann Thorac Surg. 1986;42:338–45.
Wilkins Jr EW. Role of staging in prognosis and management of thymoma. Ann Thorac Surg. 1991;51(6):888.
Loehrer Sr PJ. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. Cancer. 2001;91(11):2010.
Sperling B. Thymoma: A review of the clinical and pathological findings in 65 cases. Can J Surg. 2003;46(1):37.
Blumberg D. Thymoma: A multivariate analysis of factors predicting survival. Ann Thorac Surg. 1995;60(4):908.
Wang LS. Malignant thymoma. Cancer. 1992;70(2):443.
Wilkins KB. Clinical and pathologic predictors of survival in patients with thymoma. Ann Surg. 1999;230(4):562.
Froudarakis ME. Invasive thymoma: A clinical study of 23 cases. Respiration. 2000;68(4):376.
Fujimura S. Results of surgical treatment for thymoma based on 66 patients. J Thorac Cardiovasc Surg. 1987;93(5):708.
Do Y. CT findings in malignant tumors of thymic epithelium. J Comput Assist Tomogr. 1995;19(2):192.
van de Wijngaert FP, Kendall MD, Schuurman HJ, Rademakers LH, Kater L. Heterogeneity of epithelial cells in the human thymus. An ultrastructural study. Cell Tissue Res. 1984;237(2):227–37.
Marino M. Thymoma and thymic carcinoma. Virchows Arch. 1985;407(2):119–49.
Wick MR. Primary thymic carcinomas. Am J Surg Pathol. 1982;6(7):613.
Rios A. Prognostic factors in thymic epithelial neoplasms. Eur J Cardiothorac Surg. 2002;21(2):307.
Sassa, Mizushima Y, Kusajima Y, Sugiyama S, Noto H, Kobayashi M. Clinical study on thymoma: Assessment of prognostic factors. Anticancer Res. 1996;16(6B):3895–900.
Lardinois D. Prognostic relevance of masaoka and Müller-hermelink classification in patients with thymic tumors. Ann Thorac Surg. 2000;69(5):1550.
Latz D. Invasive thymoma: Treatment with postoperative radiation therapy. Radiology. 1997;204(3):859.
Kondo K, Yoshizawa K, Tsuyuguchi M, Kimura S, Sumitomo M, Morita J, et al. WHO histologic classification is a prognostic indicator in thymoma. Ann Thorac Surg. 2004;77(4):1183–8. 4.
Mayer R. Radiotherapy for invasive thymoma and thymic carcinoma. Strahlenther Onkol. 1999;175(6):271.
Allen MS. Benign mediastinal germ cell tumors. In: Wood DE, Thomas CR, editors. Mediastinal Tumors: Update 1995. Springer-Verlag; 1995. p. 37–42.
Zhang Z, Ren H, Yu H, Li Z, Liu H, Lu Z. Thymic carcinoid tumor–a report of 7 cases. Chin Med Sci J. 1993;8(1):48–51.
Economopoulos GC. Carcinoid tumors of the thymus. Ann Thorac Surg. 1990;50(1):58.
Asbun HJ, Calabria RP, Calmes S, Lang AG, Bloch JH. Thymic carcinoid. Am Surg. 1991;57(7):442–5.
Falkson CB. The management of thymoma: A systematic review and practice guideline. J Thorac Oncol. 2009;4(7):911.
Strollo DC. Primary mediastinal tumors. part 1. Chest. 1997;112(2):511.
Wick MR. Primary mediastinal carcinoid tumors. Am J Surg Pathol. 1982;6(3):195.
Gray GF. Thymoma. A clinicopathologic study of 54 cases. Am J Surg Pathol. 1979;3(3):235.
Lattes R. Thymoma and other tumors of the thymus. An analysis of 107 cases. Cancer. 1962;15(6):1224.
Lewis JE. Thymoma. A clinicopathologic review. Cancer. 1987;60(11):2727.
Rubin M. Clinical disorders associated with thymic tumors. Arch Intern Med. 1964;114(3):389.
Weissberg D. Thymoma. Ann Thorac Surg. 1973;16(2):141.
Masaoka A. Follow-up study of thymomas with special reference to their clinical stages. Cancer. 1981;48(11):2485.
Bernatz PE, Harrison EG, Clagett OT. Thymoma: A clinicopathologic study. J Thorac Cardiovasc Surg. 1961;42:424–44.
Kirchner T, Muller-Hermelink HK. New approaches to the diagnosis of thymic epithelial tumors. Prog Surg Pathol. 1989;10:167–89.
Cornea R, Cimpean AM, Raica M. World health organization histo-morphologic classification of thymomas. pros and cons. TMJ. 2009;59(3–4):371–7.
Detterbeck FC. Clinical value of the WHO classification system of thymoma. Ann Thorac Surg. 2006;81(6):2328.
Verley JM. Thymoma. A comparative study of clinical stages, histologic features, and survival in 200 cases. Cancer. 1985;55(5):1074.
Sawyers JL. Surgical treatment of thymomas. Arch Surg. 1968;96(5):814.
Bernatz P, Khonsari S, Harrison E, Taylor W. Thymoma: Factors influencing prognosis. Surg Clin North Am. 1973;53(4):885–92. 08.
Levine GD. Thymic hyperplasia and neoplasia: A review of current concepts. Hum Pathol. 1978;9(5):495.
Batata MA. Thymomas: Clinicopathologic features, therapy, and prognosis. Cancer. 1974;34(2):389.
Legg MA. Pathology and clinical behavior of thymomas. A survey of 51 cases. Cancer. 1965;18(9):1131.
Singhal S, Shrager JB, Rosenthal DI, LiVolsi VA, Kaiser LR. Comparison of stages I–II thymoma treated by complete resection with or without adjuvant radiation. Ann Thorac Surg. 2003;76(5):1635–42. 11.
Mangi AA, Wright CD, Allan JS, Wain JC, Donahue DM, Grillo HC, et al. Adjuvant radiation therapy for stage II thymoma. Ann Thorac Surg. 2002;74(4):1033–7. 10.
Mangi AA, Wain JC, Donahue DM, Grillo HC, Mathisen DJ, Wright CD. Adjuvant radiation of stage III thymoma: Is it necessary? Ann Thorac Surg. 2005;79(6):1834–9. 6.
Detterbeck FC, Parsons AM. Thymic tumors. Ann Thorac Surg. 2004;77(5):1860–9. 5.
Verstandig AG, Epstein DM, Miller WT, Aronchik JA, Gefter WB. Thymoma–report of 71 cases and a review. Crit Rev Diagn Imaging. 1992;33(3):201–30.
Lewis BD. Benign teratomas of the mediastinum. J Thorac Cardiovasc Surg. 1983;86(5):727.
Armstrong P. Mediastinal and hilar disorders. In: Armstrong P, Wilson AG, Dee P, Hansell DM, editors. Imaging of Diseases of the Chest. London: Mosby; 2000. p. 789–949.
Regnard JF. Prognostic factors and long-term results after thymoma resection: A series of 307 patients. J Thorac Cardiovasc Surg. 1996;112(2):376.
O'Gara RW. Tumors of the anterior mediastinum. Cancer. 1958;11(3):562.
Salyer WR. Thymoma. A clinical and pathological study of 65 cases. Cancer. 1976;37(1):229.
Wilkins Jr EW. Cases of thymoma at the Massachusetts General Hospital. J Thorac Cardiovasc Surg. 1966;52(3):322.
Legolvan DP. Thymomas. Cancer. 1977;39(5):2142.
Moore KH. Thymoma: Trends over time. Ann Thorac Surg. 2001;72(1):203.
Gawrychowski J. Thymoma–the usefulness of some prognostic factors for diagnosis and surgical treatment. Eur J Surg Oncol. 2000;26(3):203.
Haniuda M. Recurrence of thymoma: Clinicopathological features, re-operation, and outcome. J Surg Oncol. 2001;78(3):183.
Maggi G. Thymoma: Results of 241 operated cases. Ann Thorac Surg. 1991;51(1):152.
Matsushima S, Yamamoto H, Egami K, Suzuki S, Tanaka S. Evaluation of the prognostic factors after thymoma resection. Int Surg. 2001;86(2):103–6.
Nakahara K. Thymoma: Results with complete resection and adjuvant postoperative irradiation in 141 consecutive patients. J Thorac Cardiovasc Surg. 1988;95(6):1041.
Okumura M. Results of surgical treatment of thymomas with special reference to the involved organs. J Thorac Cardiovasc Surg. 1999;117(3):605.
Sakai S. Differential diagnosis between thymoma and non-thymoma by dynamic MR imaging. Acta Radiol. 2002;43(3):262.
Maher MM. Imaging of thymoma. Semin Thorac Cardiovasc Surg. 2005;17(1):12.
Rosado-de-Christenson ML. Thymoma: Radiologic-pathologic correlation. Radiographics. 1992;12(1):151.
Jeong YJ, Does CT. of thymic epithelial tumors enable us to differentiate histologic subtypes and predict prognosis? AJR. Am J Roentgenol. 2004;183(2):283.
Kubota K. PET imaging of primary mediastinal tumours. Br J Cancer. 1996;73(7):882.
Sasaki M. Differential diagnosis of thymic tumors using a combination of 11 C-methionine PET and FDG PET. J Nucl Med. 1999;40(10):1595.
Liu RS. Use of fluorine-18 fluorodeoxyglucose positron emission tomography in the detection of thymoma: A preliminary report. Eur J Nucl Med. 1995;22(12):1402.
Curran Jr W, Kornstein M, Brooks J, Turrisi A. Invasive thymoma: The role of mediastinal irradiation following complete or incomplete surgical resection. J Clin Oncol. 1988;6(11):1722–7.
Monden Y, Nakahara K, Iioka S, Nanjo S, Ohno K, Fujii Y, et al. Recurrence of thymoma: Clinicopathological features, therapy, and prognosis. Ann Thorac Surg. 1985;39(2):165–9.
Haniuda M, Morimoto M, Nishimura H, Kobayashi O, Yamanda T, Iida F. Adjuvant radiotherapy after complete resection of thymoma. Ann Thorac Surg. 1992;54(2):311–5.
Haniuda M, Miyazawa M, Yoshida K, Oguchi M, Sakai F, Izuno I, et al. Is postoperative radiotherapy for thymoma effective? Ann Surg. 1996;224(2):219.
Fornasiero A, Daniele O, Ghiotto C, Fiorentino MV, Piazza M, Fiore-Donati L, et al. Chemotherapy for invasive thymoma. A 13–year experience. Cancer. 1991;68(1):30–3.
Loehrer Sr PJ, Kim KM, Aisner SC, Livingston R, Einhorn LH, Johnson D, et al. Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: Final results of an intergroup trial. The eastern cooperative oncology group, southwest oncology group, and southeastern cancer study group. J Clin Oncol. 1994;12(6):1164–8.
Pj SL, Chen M, Kim K, Aisner SC, Einhorn LH, Livingston R, et al. Cisplatin, doxorubicin, and cyclophosphamide plus thoracic radiation therapy for limited-stage unresectable thymoma: An intergroup trial. J Clin Oncol. 1997;15(9):3093–9.
Giaccone G, Ardizzoni A, Kirkpatrick A, Clerico M, Sahmoud T, van Zandwijk N. Cisplatin and etoposide combination chemotherapy for locally advanced or metastatic thymoma. A phase II study of the European organization for research and treatment of cancer lung cancer cooperative group. J Clin Oncol. 1996;14(3):814–20.
Grassin F, Paleiron N, André M, Caliandro R, Bretel JJ, P Terrier, et al. Combined etoposide, ifosfamide, and cisplatin in the treatment of patients with advanced thymoma and thymic carcinoma. A French experience. J Thorac Oncol. 2010;5(6):893.
Lemma GL, Lee JW, Aisner SC, Langer CJ, Tester WJ, Johnson DH, et al. Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma. J Clin Oncol. 2011;29(15):2060–5.
Ito J, Sekiya M, Miura K, Yoshimi K, Suzuki T, Seyama K, et al. Refractory recurrent thymoma successfully treated with long-acting somatostatin analogue and prednisolone. Intern Med. 2009;48(12):1061–4.
Loehrer Sr PJ, Wang W, Johnson DH, Ettinger DS. Octreotide alone or with prednisone in patients with advanced thymoma and thymic carcinoma: An eastern cooperative oncology group phase II trial. J Clin Oncol. 2004;22(2):293–9.
Pettit L, El-Modir A. The role of somatostatin analogues in the treatment of advanced malignant thymomas: Case report and review of the literature. Br J Radiol. 2011;84(997):e7–10.
Souadjian JV, Enriquez P, Silverstein MN, Ppin JM. The spectrum of diseases associated with thymoma. coincidence or syndrome? Arch Intern Med. 1974;134(2):374–9.
Morgenthaler TI. Thymoma. Mayo Clin Proc. 1993;68(11):1110.
Maggi G. Thymomas: A review of 169 cases, with particular reference to results of surgical treatment. Cancer. 1986;58(3):765.
Wright M. Mediastinal tumors: Diagnosis and treatment. World J Surg. 2001;25(2):204.
Drachman DB. Myasthenia gravis. N Engl J Med. 1994;330(25):1797–810. 06/23.
Kirchner T. Well-differentiated thymic carcinoma. An organotypical low-grade carcinoma with relationship to cortical thymoma. Am J Surg Pathol. 1992;16(12):1153.
Marx A. Pathogenesis of myasthenia gravis. Virchows Arch. 1997;430(5):355.
Blossom GB. Thymectomy for myasthenia gravis. Arch Surg. 1993;128(8):855.
Sellors TH. Tumours of the thymus. Thorax. 1967;22(3):193.
Wilkins Jr EW. Thymoma: A continuing survey at the Massachusetts General Hospital. Ann Thorac Surg. 1979;28(3):252.
Slater G. Thymomas in patients with myasthenia gravis. Ann Surg. 1978;188(2):171.
Bergh NP. Tumors of the thymus and thymic region: I. clinicopathological studies on thymomas. Ann Thorac Surg. 1978;25(2):91.
Waldmann TA. Thymoma, hypogammaglobulinemia and absence of eosinophils. J Clin Invest. 1967;46:1127.
Kumura J. Post-thymectomy myasthenia gravis: Report a case of ocular myasthenia gravis after total removal of a thymoma and review of the literature. Neurology. 1967;17:413.
Wick MR, Rosai J. The endocrine thymus. In: Kovac K, Asa SI, editors. Functional Endocrine Pathology, vol. 2. Boston: Blackwell Scientific; 1991. p. 790–813.
Rosai J, Higa E. Mediastinal endocrine neoplasm, of probable thymic origin, related to carcinoid tumor. clinicopathologic study of 8 cases. Cancer. 1972;29(4):1061–74.
Wick M, Scott R, Li CY, Carney J. In: Carcinoid tumor of the thymus: A clinicopathologic report of seven cases with a review of the literature. Mayo Clin Proc. 1980;55(4):246–54.
Sugiura H, Morikawa T, Itoh K, Ono K, Okushiba S, Kondo S, et al. Thymic carcinoid in a patient with multiple endocrine neoplasia type 1: Report of a case. Surg Today. 2001;31(5):428–32.
Teh B. Thymic carcinoids in multiple endocrine neoplasia type 1. J Intern Med. 1998;243(6):501–4.
Disclosure
No potential conflicts of interest relevant to this article were reported.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Mikhail, M., Mekhail, Y. & Mekhail, T. Thymic Neoplasms: a Clinical Update. Curr Oncol Rep 14, 350–358 (2012). https://doi.org/10.1007/s11912-012-0246-8
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11912-012-0246-8